naltrexone has been researched along with dronabinol in 39 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (10.26) | 18.7374 |
| 1990's | 8 (20.51) | 18.2507 |
| 2000's | 17 (43.59) | 29.6817 |
| 2010's | 9 (23.08) | 24.3611 |
| 2020's | 1 (2.56) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Järbe, TU; Ohlin, GC | 1 |
| Cheney, DL; Costa, E; Revuelta, AV; Wood, PL | 1 |
| Coscia, CJ; Devane, WA; Howlett, AC; Spain, JW | 1 |
| Ayhan, IH; Portoghese, PS; Takemori, AE; Tulunay, FC | 1 |
| Compton, DR; Martin, BR; Mechoulam, R; Razdan, RK; Smith, PB; Welch, SP | 1 |
| Foltz, RL; Fraser, MD; Nelson, CC; Wilfahrt, JK | 1 |
| Martin, BR; Smith, PB; Welch, SP | 1 |
| Welch, SP | 2 |
| Fuentes, JA; Reche, I; Ruiz-Gayo, M | 2 |
| Lowe, J; Mason, DJ; Welch, SP | 1 |
| de Wit, H; Wachtel, SR | 1 |
| Greenwald, MK; Stitzer, ML | 1 |
| Berrendero, F; Maldonado, R | 1 |
| Delatte, MS; Moerschbaecher, JM; Winsauer, PJ | 1 |
| Gardell, LR; Lai, J; Ossipov, MH; Porreca, F; Vanderah, TW | 1 |
| Bisaga, A; Foltin, RW; Haney, M | 1 |
| Goldberg, SR; Justinova, Z; Munzar, P; Tanda, G | 1 |
| Cox, ML; Welch, SP | 1 |
| Goldberg, SR; Solinas, M | 1 |
| Acquas, E; Di Chiara, G; Fenu, S; Pisanu, A | 1 |
| Flau, K; Kathmann, M; Redmer, A; Schlicker, E; Tränkle, C | 1 |
| Haney, M | 1 |
| Becker, GL; France, CP; Gerak, LR; Li, JX; McMahon, LR | 1 |
| Cooper, ZD; Haney, M | 1 |
| Kurose, M; Meng, ID; Okada-Ogawa, A | 1 |
| Craft, RM; Wakley, AA | 1 |
| Braley, G; Carbuto, M; D'Souza, DC; Elander, J; Perry, E; Pittman, B; Radhakrishnan, R; Ranganathan, M; Sewell, RA | 1 |
| Cheng, K; Flax, SM; Rice, KC; Riley, AL; Wakeford, AG | 1 |
| Bisaga, A; Carpenter, KM; Glass, A; Haney, M; Levin, FR; Mariani, JJ; Mishlen, K; Nunes, EV; Pavlicova, M; Raby, WN; Sullivan, MA | 1 |
| Ding, H; Kiguchi, N; Kishioka, S; Ko, MC; Mabry, KM | 1 |
1 review(s) available for naltrexone and dronabinol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
6 trial(s) available for naltrexone and dronabinol
| Article | Year |
|---|---|
Naltrexone does not block the subjective effects of oral Delta(9)-tetrahydrocannabinol in humans.
Topics: Adolescent; Adult; Affect; Analysis of Variance; Behavior, Addictive; Cross-Over Studies; Double-Blind Method; Dronabinol; Female; Heart Rate; Humans; Male; Marijuana Smoking; Naltrexone; Narcotic Antagonists; Psychomotor Performance; Psychotropic Drugs | 2000 |
Antinociceptive, subjective and behavioral effects of smoked marijuana in humans.
Topics: Adolescent; Adult; Affect; Analgesics, Non-Narcotic; Double-Blind Method; Dronabinol; Female; Humans; Male; Marijuana Smoking; Middle Aged; Naltrexone; Narcotic Antagonists; Pain Measurement; Psychomotor Performance | 2000 |
Interaction between naltrexone and oral THC in heavy marijuana smokers.
Topics: Administration, Oral; Adult; Analgesics, Non-Narcotic; Analysis of Variance; Choice Behavior; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Drug Interactions; Female; Heart Rate; Humans; Male; Marijuana Smoking; Methadone; Naltrexone; Narcotic Antagonists; Pain Measurement; Psychomotor Performance; Reaction Time | 2003 |
Opioid antagonism enhances marijuana's effects in heavy marijuana smokers.
Topics: Adult; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Drug Interactions; Female; Heart Rate; Humans; Male; Marijuana Abuse; Marijuana Smoking; Naltrexone; Narcotic Antagonists; Psychomotor Performance | 2010 |
Naltrexone does not attenuate the effects of intravenous Δ9-tetrahydrocannabinol in healthy humans.
Topics: Adolescent; Adult; Attention; Behavior; Cognition; Cognition Disorders; Double-Blind Method; Dronabinol; Drug Interactions; Euphoria; Female; Hallucinogens; Humans; Inhibition, Psychological; Injections, Intravenous; Male; Marijuana Abuse; Memory; Mental Recall; Middle Aged; Naltrexone; Narcotic Antagonists; Orientation; Perception; Psychoses, Substance-Induced; Recognition, Psychology; Reward; Young Adult | 2012 |
The effects of dronabinol during detoxification and the initiation of treatment with extended release naltrexone.
Topics: Adult; Cannabinoids; Delayed-Action Preparations; Double-Blind Method; Dronabinol; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Patient Compliance; Substance Withdrawal Syndrome; Young Adult | 2015 |
32 other study(ies) available for naltrexone and dronabinol
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Stimulus effects of delta(9)-THC and its interaction with naltrexone and catecholamine blockers in rats.
Topics: Animals; Catecholamines; Columbidae; Dronabinol; Drug Interactions; Injections, Intraperitoneal; Male; Naloxone; Naltrexone; Rats; Receptors, Adrenergic, alpha | 1977 |
GABAergic mediation in the inhibition of hippocampal acetylcholine turnover rate elicited by delta 9-tetrahydrocannabinol.
Topics: Acetylcholine; Animals; Bicuculline; Dopamine; Dronabinol; gamma-Aminobutyric Acid; Hippocampus; Kinetics; Male; Muscimol; Naltrexone; Norepinephrine; Rats; Substantia Nigra | 1979 |
An assessment of the role of opioid receptors in the response to cannabimimetic drugs.
Topics: Adenylyl Cyclase Inhibitors; Animals; Cannabinoids; Cell Line; Dronabinol; Enkephalin, Leucine; Enkephalin, Leucine-2-Alanine; Enkephalin, Methionine; Etorphine; Morphine; Naltrexone; Neuroblastoma; Neurons; Receptors, Opioid; Receptors, Opioid, delta | 1986 |
Antagonism by chlornaltrexamine of some effects of delta 9-tetrahydrocannabinol in rats.
Topics: Analgesia; Animals; Dronabinol; Drug Tolerance; Humans; Hypothermia; Male; Morphine; Naloxone; Naltrexone; Narcotic Antagonists; Nitrogen Mustard Compounds; Rats; Receptors, Opioid; Substance-Related Disorders | 1981 |
The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice.
Topics: Analgesics; Animals; Arachidonic Acids; Binding, Competitive; Brain; Calcium Channel Blockers; Cyclohexanols; Dronabinol; Drug Administration Routes; Drug Interactions; Endocannabinoids; Male; Membranes; Mice; Mice, Inbred ICR; Naltrexone; Polyunsaturated Alkamides; Receptors, Purinergic P2; Tritium | 1994 |
Gas chromatography/tandem mass spectrometry measurement of delta 9-tetrahydrocannabinol, naltrexone, and their active metabolites in plasma.
Topics: Dronabinol; Gas Chromatography-Mass Spectrometry; Humans; Naltrexone; Sensitivity and Specificity | 1993 |
Interactions between delta 9-tetrahydrocannabinol and kappa opioids in mice.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics; Animals; Benzofurans; Dronabinol; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, D-Penicillamine (2,5)-; Enkephalins; Male; Mice; Mice, Inbred ICR; Naltrexone; Pyrrolidines; Receptors, Opioid, kappa | 1994 |
Blockade of cannabinoid-induced antinociception by norbinaltorphimine, but not N,N-diallyl-tyrosine-Aib-phenylalanine-leucine, ICI 174,864 or naloxone in mice.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics; Animals; Dronabinol; Enkephalin, D-Penicillamine (2,5)-; Enkephalin, Leucine; Enkephalins; Infusions, Intravenous; Injections, Spinal; Mice; Naloxone; Naltrexone; Pyrrolidines; Receptors, Opioid; Receptors, Opioid, delta | 1993 |
A role for central cannabinoid and opioid systems in peripheral delta 9-tetrahydrocannabinol-induced analgesia in mice.
Topics: Analgesics; Animals; Central Nervous System; Dose-Response Relationship, Drug; Dronabinol; Dynorphins; Injections, Intravenous; Male; Mice; Naltrexone; Narcotic Antagonists; Pain Measurement; Peripheral Nervous System; Piperidines; Pyrazoles; Reaction Time; Receptors, Cannabinoid; Receptors, Drug; Receptors, Opioid; Rimonabant | 1996 |
Potentiation of delta 9-tetrahydrocannabinol-induced analgesia by morphine in mice: involvement of mu- and kappa-opioid receptors.
Topics: Analgesia; Analgesics, Opioid; Animals; Binding Sites; Dronabinol; Drug Synergism; Male; Mice; Morphine; Naltrexone; Narcotic Antagonists; Pain Measurement; Receptors, Opioid, kappa; Receptors, Opioid, mu | 1996 |
Characterization of anandamide-induced tolerance: comparison to delta 9-THC-induced interactions with dynorphinergic systems.
Topics: Analgesics; Animals; Arachidonic Acids; Cannabinoids; Cyclohexanols; Dose-Response Relationship, Drug; Dronabinol; Drug Tolerance; Dynorphins; Endocannabinoids; Injections, Intraperitoneal; Injections, Spinal; Mice; Naltrexone; Narcotic Antagonists; Pain Measurement; Polyunsaturated Alkamides; Receptors, Cannabinoid; Receptors, Drug | 1997 |
Cannabinoid modulation of dynorphin A: correlation to cannabinoid-induced antinociception.
Topics: Analgesics; Animals; Cannabinoids; Cyclohexanols; Dimethyl Sulfoxide; Dronabinol; Dynorphins; Injections, Spinal; Male; Naltrexone; Narcotic Antagonists; Nociceptors; Pain; Pain Measurement; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Rimonabant | 1999 |
Involvement of the opioid system in the anxiolytic-like effects induced by Delta(9)-tetrahydrocannabinol.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Darkness; Dronabinol; Endorphins; Light; Male; Mice; Naltrexone; Narcotic Antagonists; Piperidines; Pyrazoles; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Rimonabant | 2002 |
Tolerance to the disruptive effects of Delta(9)-THC on learning in rats.
Topics: Animals; Color Perception; Conditioning, Operant; Dose-Response Relationship, Drug; Dronabinol; Drug Tolerance; Hallucinogens; Learning; Male; Naltrexone; Narcotic Antagonists; Piperidines; Pyrazoles; Rats; Rats, Long-Evans; Reinforcement Schedule; Rimonabant | 2002 |
Dynorphin-independent spinal cannabinoid antinociception.
Topics: Analgesics; Analgesics, Non-Narcotic; Animals; Benzoxazines; Dose-Response Relationship, Drug; Dronabinol; Dynorphins; Injections, Spinal; Male; Mice; Mice, Knockout; Morpholines; Naltrexone; Naphthalenes; Pain; Pain Measurement; Reference Values; Reproducibility of Results; Sensitivity and Specificity; Single-Blind Method; Species Specificity; Spinal Cord | 2002 |
The opioid antagonist naltrexone reduces the reinforcing effects of Delta 9 tetrahydrocannabinol (THC) in squirrel monkeys.
Topics: Analgesics, Non-Narcotic; Anesthetics, Local; Animals; Behavior, Animal; Cocaine; Conditioning, Operant; Dose-Response Relationship, Drug; Dronabinol; Drug Interactions; Male; Naltrexone; Narcotic Antagonists; Reinforcement Schedule; Reinforcement, Psychology; Saimiri; Self Administration | 2004 |
The antinociceptive effect of Delta9-tetrahydrocannabinol in the arthritic rat.
Topics: Animals; Arthritis, Experimental; Cannabinoid Receptor Antagonists; Dose-Response Relationship, Drug; Dronabinol; Dynorphins; Enkephalin, Leucine; Enkephalin, Methionine; Freund's Adjuvant; Injections, Intradermal; Injections, Intraperitoneal; Male; Morphine; Mycobacterium; Naloxone; Naltrexone; Narcotic Antagonists; Pain; Pain Measurement; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptors, Opioid; Rimonabant | 2004 |
Involvement of mu-, delta- and kappa-opioid receptor subtypes in the discriminative-stimulus effects of delta-9-tetrahydrocannabinol (THC) in rats.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics, Non-Narcotic; Animals; Benzamides; Conditioning, Operant; Discrimination Learning; Discrimination, Psychological; Dose-Response Relationship, Drug; Dronabinol; Food; Hallucinogens; Heroin; Male; Naltrexone; Narcotic Antagonists; Narcotics; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Reinforcement, Psychology | 2005 |
Modulation of Delta(9)-THC-induced increase of cortical and hippocampal acetylcholine release by micro opioid and D(1) dopamine receptors.
Topics: Acetylcholine; Animals; Behavior, Animal; Benzazepines; Dopamine Antagonists; Dronabinol; Drug Interactions; Hippocampus; Male; Microdialysis; Naloxone; Naltrexone; Narcotic Antagonists; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Opioid, mu; Time Factors | 2006 |
Cannabidiol is an allosteric modulator at mu- and delta-opioid receptors.
Topics: Allosteric Regulation; Analgesics, Opioid; Animals; Cannabidiol; Cerebral Cortex; Dose-Response Relationship, Drug; Dronabinol; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Male; Naloxone; Naltrexone; Narcotic Antagonists; Rats; Rats, Wistar; Receptors, Opioid, delta; Receptors, Opioid, mu | 2006 |
Opioid antagonism of cannabinoid effects: differences between marijuana smokers and nonmarijuana smokers.
Topics: Adult; Blood Pressure; Cannabinoids; Dronabinol; Female; Hallucinogens; Heart Rate; Humans; Male; Marijuana Smoking; Mental Recall; Methadone; Middle Aged; Naltrexone; Narcotic Antagonists; Narcotics; Psychomotor Performance; Pupil; Recognition, Psychology; Sex Characteristics; Surveys and Questionnaires | 2007 |
Interactions between Delta(9)-tetrahydrocannabinol and mu opioid receptor agonists in rhesus monkeys: discrimination and antinociception.
Topics: Analgesics; Analgesics, Opioid; Animals; Data Interpretation, Statistical; Discrimination, Psychological; Dose-Response Relationship, Drug; Dronabinol; Drug Interactions; Female; Heroin; Hot Temperature; Hypnotics and Sedatives; Macaca mulatta; Male; Midazolam; Morphine; Morphine Dependence; Naltrexone; Narcotic Antagonists; Pain Measurement; Receptors, Opioid, mu; Substance Withdrawal Syndrome | 2008 |
Attenuation of cannabinoid-induced inhibition of medullary dorsal horn neurons by a kappa-opioid receptor antagonist.
Topics: Animals; Benzoxazines; Calcium Channel Blockers; Cannabinoids; Dronabinol; Male; Medulla Oblongata; Morpholines; Naltrexone; Naphthalenes; Narcotic Antagonists; Patch-Clamp Techniques; Posterior Horn Cells; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa | 2010 |
THC-methadone and THC-naltrexone interactions on discrimination, antinociception, and locomotion in rats.
Topics: Analgesics, Non-Narcotic; Analgesics, Opioid; Animals; Discrimination Learning; Disease Models, Animal; Dose-Response Relationship, Drug; Dronabinol; Drug Interactions; Locomotion; Male; Methadone; Naltrexone; Narcotic Antagonists; Pain; Rats; Rats, Sprague-Dawley; Receptors, Opioid, mu | 2011 |
Effect of norbinaltorphimine on ∆⁹-tetrahydrocannabinol (THC)-induced taste avoidance in adolescent and adult Sprague-Dawley rats.
Topics: Aging; Animals; Appetite Stimulants; Avoidance Learning; Dose-Response Relationship, Drug; Dronabinol; Male; Naltrexone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Taste; Taste Perception | 2015 |
Functional consequences of short-term exposure to opioids versus cannabinoids in nonhuman primates.
Topics: Analgesics, Opioid; Animals; Cannabinoid Receptor Agonists; Cannabinoids; Dose-Response Relationship, Drug; Dronabinol; Female; Heroin; Male; Morphine; Naltrexone; Rimonabant | 2023 |